Central nervous system tuberculosis

INTRODUCTION

Central nervous system (CNS) tuberculosis (TB) includes three clinical categories: meningitis, intracranial tuberculoma, and spinal tuberculous arachnoiditis. All three forms of CNS infection are encountered frequently in regions of the world where the incidence of TB is high and the prevalence of post-primary dissemination is common among children and young adults [1,2]. In regions where the incidence rates are low, such as North America and Western Europe, extrapulmonary manifestations of diseases are seen primarily in adults with reactivation infection, and the dominant form of CNS disease is meningitis.

The pathogenesis, clinical presentation, diagnosis, and management of central nervous system tuberculous will be reviewed here. The general principles of treatment of TB are discussed separately. (See "Treatment of pulmonary tuberculosis in HIV-negative patients".)

PATHOGENESIS

Scattered tuberculous foci (tubercles) are established in the brain, meninges, or adjacent bone during the bacillemia that follows primary infection or late reactivation TB elsewhere in the body. (See "Microbiology and pathogenesis of tuberculosis".)

The chance occurrence of a subependymal tubercle, with progression and rupture into the subarachnoid space, is the critical event in the development of tuberculous meningitis [3]. The widespread and dense distribution of infectious foci seen in association with progressive miliary tuberculosis greatly increases the chance that juxta-ependymal tubercles will be established. (See "Epidemiology and pathology of extrapulmonary and miliary tuberculosis".)

Consequently, meningitis develops most commonly as a complication of post-primary infection in infants and young children and from chronic reactivation bacillemia in older adults with immune deficiency caused by aging, alcoholism, malnutrition, malignancy, or human immunodeficiency virus (HIV) infection. Advancing age or head trauma may also lead to destabilization of an established quiescent focus resulting in meningitis in the absence of any evidence of generalized infection.

                                   

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Mar 2014. | This topic last updated: Nov 8, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. al-Deeb SM, Yaqub BA, Sharif HS, Motaery KR. Neurotuberculosis: a review. Clin Neurol Neurosurg 1992; 94 Suppl:S30.
  2. Bahemuka M, Murungi JH. Tuberculosis of the nervous system. A clinical, radiological and pathological study of 39 consecutive cases in Riyadh, Saudi Arabia. J Neurol Sci 1989; 90:67.
  3. Rich AR, McCordock HA. Pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hosp 1933; 52:5.
  4. Dastur DK, Manghani DK, Udani PM. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am 1995; 33:733.
  5. Chan KH, Cheung RT, Lee R, et al. Cerebral infarcts complicating tuberculous meningitis. Cerebrovasc Dis 2005; 19:391.
  6. Poltera AA. Thrombogenic intracranial vasculitis in tuberculous meningitis. A 20 year "post mortem" survey. Acta Neurol Belg 1977; 77:12.
  7. Hawn TR, Dunstan SJ, Thwaites GE, et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J Infect Dis 2006; 194:1127.
  8. CDC, reported tuberculosis in the United States, 2004. Atlanta, GA. US Department of Health and Human Services, CDC. September 2005.
  9. Farer LS, Lowell AM, Meador MP. Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979; 109:205.
  10. Hinman AR. Tuberculous meningitis at Cleveland Metropolitan General Hospital 1959 to 1963. Am Rev Respir Dis 1967; 95:670.
  11. Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA 1979; 241:264.
  12. Farinha NJ, Razali KA, Holzel H, et al. Tuberculosis of the central nervous system in children: a 20-year survey. J Infect 2000; 41:61.
  13. Kent SJ, Crowe SM, Yung A, et al. Tuberculous meningitis: a 30-year review. Clin Infect Dis 1993; 17:987.
  14. Udani PM, Dastur DK. Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations. J Neurol Sci 1970; 10:541.
  15. STREPTOMYCIN treatment of tuberculous meningitis. Lancet 1948; 1:582.
  16. Braun MM, Byers RH, Heyward WL, et al. Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med 1990; 150:1913.
  17. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992; 326:668.
  18. Dubé MP, Holtom PD, Larsen RA. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 1992; 93:520.
  19. Sánchez-Portocarrero J, Pérez-Cecilia E, Jiménez-Escrig A, et al. Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol 1996; 53:671.
  20. Hakim JG, Gangaidzo IT, Heyderman RS, et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 2000; 14:1401.
  21. Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 2000; 181:118.
  22. Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009; 48:e96.
  23. Asselman V, Thienemann F, Pepper DJ, et al. Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS 2010; 24:2871.
  24. Tuon FF, Mulatti GC, Pinto WP, et al. Immune reconstitution inflammatory syndrome associated with disseminated mycobacterial infection in patients with AIDS. AIDS Patient Care STDS 2007; 21:527.
  25. Lee CH, Lui CC, Liu JW. Immune reconstitution syndrome in a patient with AIDS with paradoxically deteriorating brain tuberculoma. AIDS Patient Care STDS 2007; 21:234.
  26. Marais S, Meintjes G, Pepper DJ, et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis 2013; 56:450.
  27. Merritt HH, Fremont-Smith F. The cerebrospinal fluid, WB Saunders, Philadelphia 1938.
  28. Karandanis D, Shulman JA. Recent survey of infectious meningitis in adults: review of laboratory findings in bacterial, tuberculous, and aseptic meningitis. South Med J 1976; 69:449.
  29. SMITH HV. TUBERCULOUS MENINGITIS. Int J Neurol 1964; 4:134.
  30. Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 2004; 42:378.
  31. Kaneko K, Onodera O, Miyatake T, Tsuji S. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR). Neurology 1990; 40:1617.
  32. Noordhoek GT, Kolk AH, Bjune G, et al. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol 1994; 32:277.
  33. Bonington A, Strang JI, Klapper PE, et al. Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in early diagnosis of tuberculous meningitis. J Clin Microbiol 1998; 36:1251.
  34. Pai M, Flores LL, Pai N, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003; 3:633.
  35. Jayanthi U, Madhavan HN, Therese KL. Nucleic acid amplification tests for diagnosis of tuberculous meningitis. Lancet Infect Dis 2004; 4:9; discussion 11.
  36. Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177:787.
  37. Duo L, Ying B, Song X, et al. Molecular profile of drug resistance in tuberculous meningitis from southwest china. Clin Infect Dis 2011; 53:1067.
  38. Patel VB, Theron G, Lenders L, et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med 2013; 10:e1001536.
  39. Vadwai V, Boehme C, Nabeta P, et al. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 2011; 49:2540.
  40. Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012; 40:442.
  41. Bernaerts A, Vanhoenacker FM, Parizel PM, et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 2003; 13:1876.
  42. Bhargava S, Gupta AK, Tandon PN. Tuberculous meningitis--a CT study. Br J Radiol 1982; 55:189.
  43. Ozateş M, Kemaloglu S, Gürkan F, et al. CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol 2000; 41:13.
  44. Chan KH, Cheung RT, Fong CY, et al. Clinical relevance of hydrocephalus as a presenting feature of tuberculous meningitis. QJM 2003; 96:643.
  45. Kingsley DP, Hendrickse WA, Kendall BE, et al. Tuberculous meningitis: role of CT in management and prognosis. J Neurol Neurosurg Psychiatry 1987; 50:30.
  46. Schoeman J, Hewlett R, Donald P. MR of childhood tuberculous meningitis. Neuroradiology 1988; 30:473.
  47. Offenbacher H, Fazekas F, Schmidt R, et al. MRI in tuberculous meningoencephalitis: report of four cases and review of the neuroimaging literature. J Neurol 1991; 238:340.
  48. Jinkins JR. Computed tomography of intracranial tuberculosis. Neuroradiology 1991; 33:126.
  49. Stevens DL, Everett ED. Sequential computerized axial tomography in tuberculous meningitis. JAMA 1978; 239:642.
  50. Weisberg LA. Granulomatous diseases of the CNS as demonstrated by computerized tomography. Comput Radiol 1984; 8:309.
  51. Harder E, Al-Kawi MZ, Carney P. Intracranial tuberculoma: conservative management. Am J Med 1983; 74:570.
  52. Traub M, Colchester AC, Kingsley DP, Swash M. Tuberculosis of the central nervous system. Q J Med 1984; 53:81.
  53. Whelan MA, Stern J. Intracranial tuberculoma. Radiology 1981; 138:75.
  54. Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol 2000; 15:207.
  55. Wadia NH, Dastur DK. Spinal meningitides with radiculo-myelopathy. 1. Clinical and radiological features. J Neurol Sci 1969; 8:239.
  56. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1998; 53:536.
  57. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603.
  58. Chatterjee VK, Buchanan DR, Friedmann AI, Green M. Ocular toxicity following ethambutol in standard dosage. Br J Dis Chest 1986; 80:288.
  59. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. Geneva: WHO, 2004.
  60. Thwaites GE, Lan NT, Dung NH, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192:79.
  61. Patel VB, Padayatchi N, Bhigjee AI, et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004; 38:851.
  62. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351:1741.
  63. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997; 99:226.
  64. Girgis NI, Farid Z, Kilpatrick ME, et al. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991; 10:179.
  65. VanBeusekom GT. Complications in hydrocephalus shunting procedure. In: Advances in Neurosurgery, 6th ed, Wellenbur R, Brock M, Klinger M (Eds), Springer-Verlag, New York City 1968. p.28.